Canada became the third country to authorize the use of the Covid-19 vaccine, developed by Pfizer-BioNTech.
Canada became the third country to authorize the use of the Covid-19 vaccine, developed by Pfizer-BioNTech. Recognizes the views of its most vulnerable citizens before the Food and Drug Administration and Europe’s leading regulator.
- Canada has now joined the United Kingdom and Bahrain in approving Pfizer-BioNTech.
- Prime Minister Justin Trudeau told the WSJ on Monday that the approval was immediate.
- Canadian officials say they have purchased 126 freezers to store the Covid-19 vaccine.
- Visit Lifestyle Uganda homepage for more stories like this.
Canada will now begin its immunization roll out early next week – a tough challenge for a country that is the second largest in the world by land area.
The country is scheduled to launch vaccines next week, arguing that a portfolio of vaccine candidates is very different in large economies.
F.D.A. will allow the use of the vaccine early this weekend after a two-dose study has concluded, even after the first injection the benefit has been ”reduced about half of the risk of getting Covid-19”. After the second dose, the vaccine was found to be 95% effective.
- Advertisement -
The European pharmaceutical company says a decision on the Pfizer-BioNTech shot or Moderna Inc. vaccine could be made by the end of this month.
The Pfizer-BioNTech Covid-19 vaccine has now been approved by Canada, the United Kingdom and Bahrain in the past week.
Canadian regulators have issued a notice of accreditation online.
A spokesman for Pfizer’s Canadian division said on Wednesday that Pfizer would deliver up to 76 million doses of the vaccine to Canada. The deal includes a firm agreement to buy Canada at least 20 million doses with a will of more than 56 million.
On Monday, Canada said it would provide 249,000 initial doses in advance, in anticipation of vaccinations starting early next week.
- Advertisement -
Canadian Prime Minister Justin Trudeau told The Wall Street Journal on Monday that the approval was immediate. He said the pending vaccine, coupled with the release-occupation fiscal policy, would spur economic recovery expected to gather strength by mid-2021.
The goal is to vaccinate three million Canadians by the end of the first quarter and the majority of the country’s 38 million residents by September, Trudeau said.
To date, Canada’s vaccination strategy has focused on accumulating as many doses as possible on an individual basis. In that sense, Canada is leading the world. Trudeau and other officials spoke proudly.
- Advertisement -
To date, Canada has said it will approach more than $400 million but has not disclosed the financial terms of the agreements reached with the seven leading candidates.
“Canada set out to create the best and most diverse portfolio of possible vaccines for any other country,” Mr Trudeau told the journal’s CEO during a council summit this week.
“With vaccines starting to get into people’s hands, next week we see the beginning of the end of the epidemic.”
Amir Attaran, a professor at the School of Epidemiology at the University of Ottawa, said Canada was exaggerating its success in accessing vaccines.
By the end of March, Canada will receive three million US dollars Only part of the expected 50 million. “It’s not very good,” Attaran said. Even after adjusting the population, it is leaving Canada, he said.
Earl Brown, a virologist and professor at the University of Ottawa, has done an admirable job of covering sites of potential vaccines in Canada because it is not clear what would be most effective. “You can’t criticize them at that point,” he said.
“You never know which manufacturers are going to travel and fall into the race.”
Canada, for example, has an agreement with Moderna to receive a 56 million dose of its Covid-19 vaccine candidate, and regulators expect a ruling on that vaccine within the next month.
Mr Trudeau believes that if the modern vaccine is approved, “more communities and northern Canadians can be reached” because its transportation is less complicated than Pfizer’s.
The Pfizer-BioNTech vaccine is difficult to store and carry. It should be refrigerated at a temperature of minus 112 to minus 76 degrees Fahrenheit to keep for six months. Vaccination is possible for 120 hours under normal refrigeration.
Health Canada officials say they have purchased 126 freezers to store the Covid-19 vaccine, including 26 for the ultrasonic temperature required for the Pfizer-BioNTech shot.
The first beneficiary of Covid-19 vaccine was identified by Canadian public health officials as residents of nursing homes.
About three-quarters of the country’s nearly 13,000 Covid-19-related deaths appear to be from these companies, according to Ryerson University ageing Institute.
Theresa Tom, Canada’s chief medical officer, said there will be challenges because authorities will not be able to easily move nursing home residents to one of the initial 14 vaccination sites designed to pay for the Pfizer-BioNTech shot.
“I think this is a liquid situation,” he said, adding that officials are working on a solution.